Publications CNRGH

Nonlethal CHRNA1-Related Congenital Myasthenic Syndrome with a Homozygous Null Mutation

Published on 2 October 2023

Nonlethal CHRNA1-Related Congenital Myasthenic Syndrome with a Homozygous Null Mutation
Description
Date de publication
Auteurs	Neto OA, Heise CO, Moreno CDM, Estephan ED, Mesrob L, Lechner D, Boland A, Deleuze JF, Oliveira ASB, Reed UC, Biancalana V, Laporte J and Zanoteli E
Revue	Canadian Journal of Neurological Sciences 44 (1), 125-127, 2017
Année	2,017
Département / Service	JACOB/CNRGH
Laboratoire	LEE, LHD
Impact Factor
Institut	JACOB
url DOI	10.1017/cjn.2016.322

Go back to list

Top page

Alternative and Atomic Energies Agency

CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.

François Jacob Institute of biology

In the same section :

Nonlethal CHRNA1-Related Congenital Myasthenic Syndrome with a Homozygous Null Mutation

Browse the site

Alternative and Atomic Energies Agency

Browse the portal

François Jacob Institute of biology

François Jacob Institute of biology

Departments and services

National Infrastructures

Scientific News

In the same section :

Nonlethal CHRNA1-Related Congenital Myasthenic Syndrome with a Homozygous Null Mutation

Browse the site

Alternative and Atomic Energies Agency

Browse the portal